Abstract
BackgroundComorbidities decrease the opportunity to administer treatment strategies involving methotrexate (MTX) and biologics to patients with active rheumatoid arthritis (RA).ObjectivesTo clarify the impact of comorbidities on disease activity and treatment...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
